[Congressional Record Volume 171, Number 34 (Thursday, February 20, 2025)]
[Senate]
[Page S1272]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1014. Ms. ALSOBROOKS (for herself, Ms. Cortez Masto, and Mr. Kim) 
submitted an amendment intended to be proposed by her to the concurrent 
resolution S. Con. Res. 7, setting forth the congressional budget for 
the United States Government for fiscal year 2025 and setting forth the 
appropriate budgetary levels for fiscal years 2026 through 2034; which 
was ordered to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   PREVENTING THE REPEAL OF DRUG PRICING 
                   PROVISIONS IN STATUTE.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     reducing health care prices, which may include preventing the 
     repeal of provisions related to reforms to drug pricing, or 
     increasing costs for American families, by the amounts 
     provided in such legislation for those purposes, provided 
     that such legislation would not increase the deficit over the 
     period of the total of fiscal years 2025 through 2034.
                                 ______